期刊
GASTROENTEROLOGY
卷 159, 期 3, 页码 1148-1150出版社
W B SAUNDERS CO-ELSEVIER INC
DOI: 10.1053/j.gastro.2020.05.014
关键词
-
资金
- Agencia Nacional de Investigacion y Desarrollo (ANID) of Chile [FONDECYT 1161971]
- FLUOMICS Consortium (NIAID) - National Institutes of Health (NIH), United States [U19AI135972]
- CRIP (Center for Research on Influenza Pathogenesis), an NIH [HHSN272201400008C]
The pandemic caused by a novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) can cause several gastrointestinal (GI) symptoms. A recent systematic review showed a prevalence of GI symptoms in 17.6%. The most frequent manifestations were anorexia (26.8%), diarrhea (12.5%), nausea/vomiting (10.2%), and abdominal pain (9.2%),1 and recent reports showed the detection of viral RNA in stools for prolonged periods (70.3%).1 We established the frequency and impact of GI symptoms, and viral presence in stools among Chilean patients infected with SARS-CoV-2.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据